2020 | Lewis Antigen Phenotype and Survival of Patients With Pancreatic Cancer | PANCREAS |
2020 | 췌장암의 항암치료와 방사선 치료 최신 지견
| Korean Journal of Pancreas and Biliary Tract(대한췌담도학회지) |
2020 | Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging? | PANCREATOLOGY |
2020 | Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study
| JOURNAL OF CLINICAL MEDICINE |
2020 | Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2020 | FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
2020 | A Robotic Biopsy Endoscope with Magnetic 5-DOF Locomotion and a Retractable Biopsy Punch
| MICROMACHINES |
2020 | Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer
| GUT AND LIVER |
2020 | A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells | CELL METABOLISM |
2019 | Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma | PANCREAS |
2019 | Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX Chemotherapy | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
2019 | A novel lumen-apposing metal stent with an anti-reflux valve for endoscopic ultrasound-guided drainage of pseudocysts and walled-off necrosis: A pilot study
| PLoS One |
2019 | Establishment of pancreatic cancer cell lines with endoscopic ultrasound‐guided biopsy via conditionally reprogrammed cell culture
| CANCER MEDICINE |
2019 | Bleeding Complications and Clinical Safety of Endoscopic Retrograde Cholangiopancreatography in Patients with Liver Cirrhosis
| YONSEI MEDICAL JOURNAL |
2019 | KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study | HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL |
2018 | Clinical Value of Contrast-Enhanced Harmonic Endoscopic Ultrasonography in the Differential Diagnosis of Pancreatic and Gallbladder Masses
| CLINICAL ENDOSCOPY |
2018 | Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
2018 | Clinical Outcomes of Bilateral Stent-in-Stent Placement Using Self-Expandable Metallic Stent for High-Grade Malignant Hilar Biliary Obstruction
| YONSEI MEDICAL JOURNAL |
2018 | Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
2018 | Revision of bilateral self-expandable metallic stents placed using the stent-in-stent technique for malignant hilar biliary obstruction | HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL |
2018 | Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP: a prospective randomized controlled trial | GASTROINTESTINAL ENDOSCOPY |
2018 | Oncologic outcomes after radical surgery for periampullary cancer in octogenarians
| Annals of Hepato-biliary-pancreatic Surgery |
2018 | Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer
| SCIENTIFIC REPORTS |
2018 | Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis
| PLOS ONE |
2017 | Risk factors associated with adverse events during endoscopic ultrasound-guided tissue sampling
| PLOS ONE |
2017 | Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer "in a Korean" population: A single-center cohort study | SEMINARS IN ONCOLOGY |
2017 | Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer | CHEMOTHERAPY |
2017 | Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2017 | Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer
| GUT AND LIVER |
2017 | The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
2017 | A prospective randomized study for efficacy of an uncovered double bare metal stent compared to a single bare metal stent in malignant biliary obstruction | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
2017 | Best options for preoperative biliary drainage in patients with Klatskin tumors | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
2017 | Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
| WORLD JOURNAL OF GASTROENTEROLOGY |
2017 | A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea.
| MEDICINE |
2016 | Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
| YONSEI MEDICAL JOURNAL |
2016 | Visceral Obesity is Associated with Poor Prognosis in Pancreatic Adenocarcinoma | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
2016 | A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2016 | Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer.
| PLOS ONE |
2016 | Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses
| PLOS ONE |
2016 | Statin Use and Its Impact on Survival in Pancreatic Cancer Patients Cancer Patients
| MEDICINE |
2016 | Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existingdiabetes existingdiabetes mellitus type 2 | DIGESTIVE AND LIVER DISEASE |
2016 | A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer.
| GUT AND LIVER |
2016 | Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer | CHEMOTHERAPY |
2016 | Cholecystectomy for Prevention of Recurrence after Endoscopic Clearance of Bile Duct Stones in Korea
| YONSEI MEDICAL JOURNAL |
2015 | Conventional versus Analgesia-Oriented Combination Sedation on Recovery Profiles and Satisfaction after ERCP: A Randomized Trial
| PLOS ONE |
2015 | The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement
| MEDICINE |
2015 | Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial | ENDOSCOPY |
2014 | 다발성 글루카곤 생성 내분비세포종을 동반한 췌장 알파세포의 Nesidioblastosis 및 과다증식 1예
| Korean Journal of Gastroenterology |
2014 | Full-dose gemcitabine is a more effective chemotherapeutic agent than 5-fluorouracil for concurrent chemoradiotherapy as first-line treatment in locally advanced pancreatic cancer | CHEMOTHERAPY |